Apolo AB - Search Results

1

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.

Girardi DM, Niglio SA, Mortazavi A, Nadal R, Lara P, Pal SK, Saraiya B, Cordes L, Ley L, Ortiz OS, Cadena J, Diaz C, Bagheri H, Redd B, Steinberg SM, Costello R, Chan KS, Lee MJ, Lee S, Yu Y, Gurram S, Chalfin HJ, Valera V, Figg WD, Merino M, Toubaji A, Streicher H, Wright JJ, Sharon E, Parnes HL, Ning YM, Bottaro DP, Cao L, Trepel JB, Apolo AB. Girardi DM, et al. Among authors: apolo ab. Clin Cancer Res. 2022 Apr 1;28(7):1353-1362. doi: 10.1158/1078-0432.CCR-21-3726. Clin Cancer Res. 2022. PMID: 35031545 Free PMC article.

2

Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy.

Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB. Alarcon SV, et al. Among authors: apolo ab. Curr Mol Med. 2012 Nov 1;12(9):1125-41. doi: 10.2174/156652412803306729. Curr Mol Med. 2012. PMID: 22804236 Free PMC article. Review.

3

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

Apolo AB, Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF. Apolo AB, et al. J Natl Cancer Inst. 2013 Apr 3;105(7):499-503. doi: 10.1093/jnci/djt015. Epub 2013 Feb 14. J Natl Cancer Inst. 2013. PMID: 23411591 Free PMC article.

4

Targeted therapies in urothelial carcinoma.

Ghosh M, Brancato SJ, Agarwal PK, Apolo AB. Ghosh M, et al. Among authors: apolo ab. Curr Opin Oncol. 2014 May;26(3):305-20. doi: 10.1097/CCO.0000000000000064. Curr Opin Oncol. 2014. PMID: 24685646 Free PMC article. Review.

5

Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma.

Yavuz S, Apolo AB, Kummar S, del Rivero J, Madan RA, Shawker T, Reynolds J, Celi FS. Yavuz S, et al. Among authors: apolo ab. Thyroid. 2014 Aug;24(8):1223-31. doi: 10.1089/thy.2013.0621. Epub 2014 Jun 5. Thyroid. 2014. PMID: 24724719 Free PMC article. Clinical Trial.

6

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.

Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS. Apolo AB, et al. Urol Oncol. 2014 Jul;32(5):637-44. doi: 10.1016/j.urolonc.2013.12.012. Epub 2014 May 16. Urol Oncol. 2014. PMID: 24840869 Free PMC article.

7

Phase Ib/II trial of gemcitabine, cisplatin, and lenalidomide as first-line therapy in patients with metastatic urothelial carcinoma.

Agarwal N, Apolo AB, Tsao CK, Lee KM, Godbold JH, Soto R, Poole A, Gimpel-Tetra K, Lowe N, Oh WK, Galsky MD. Agarwal N, et al. Among authors: apolo ab. Oncologist. 2014 Sep;19(9):915-6. doi: 10.1634/theoncologist.2014-0153. Epub 2014 Jul 22. Oncologist. 2014. PMID: 25052451 Free PMC article. Clinical Trial.

8

Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.

McNeil BK, Sorbellini M, Grubb RL 3rd, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, Pinto PA, Bottaro DP. McNeil BK, et al. J Transl Med. 2014 Oct 21;12:199. doi: 10.1186/1479-5876-12-199. J Transl Med. 2014. PMID: 25335552 Free PMC article.

9

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

Karzai FH, Apolo AB, Cao L, Madan RA, Adelberg DE, Parnes H, McLeod DG, Harold N, Peer C, Yu Y, Tomita Y, Lee MJ, Lee S, Trepel JB, Gulley JL, Figg WD, Dahut WL. Karzai FH, et al. Among authors: apolo ab. BJU Int. 2015 Oct;116(4):546-55. doi: 10.1111/bju.12986. Epub 2015 Jun 8. BJU Int. 2015. PMID: 25407442 Free PMC article. Clinical Trial.

10

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Zuo RC, Apolo AB, DiGiovanna JJ, Parnes HL, Keen CM, Nanda S, Dahut WL, Cowen EW. Zuo RC, et al. Among authors: apolo ab. JAMA Dermatol. 2015 Feb;151(2):170-7. doi: 10.1001/jamadermatol.2014.2734. JAMA Dermatol. 2015. PMID: 25427282 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters